Radford, John

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 1,685

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

Laverty, H., Benson, C., Cartwright, E., Cross, M., Garland, C., Hammond, T., Holloway, C., McMahon, N., Milligan, J., Park, B., et al. (2011) · British Journal of Pharmacology

Animal testing and alternativesCardiac electrophysiology and arrhythmias

Cited by 363

Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab

Kaminski, M. S., Radford, J. A., Gregory, S. A., Leonard, J. P., Knox, S. J., Kroll, S., & Wahl, R. L. (2005) · Journal of Clinical Oncology

Lymphoma Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications

Cited by 95